Related Experiment Video
Updated: Sep 26, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Functional Characterization of Cardiac Actin Mutants Causing Hypertrophic (p.A295S) and Dilated Cardiomyopathy
Roua Hassoun1,2, Constanze Erdmann3, Sebastian Schmitt4
1Institut für Forschung und Lehre (IFL), Molecular and Experimental Cardiology, Medical Faculty, Ruhr University Bochum, D-44791 Bochum, Germany.
Insights
Human cardiac actin mutants linked to cardiomyopathy were studied. These actin variants affect filament formation and calcium sensitivity, with potential therapeutic implications for dilated cardiomyopathy.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Protein Biochemistry
Background:
- Cardiomyopathies, including hypertrophic (HCM) and dilated (DCM) forms, are often linked to mutations in cardiac actin.
- Understanding the molecular mechanisms of these mutations is crucial for developing targeted therapies.
Purpose of the Study:
- To characterize the structural and functional properties of human wild-type (wt) cardiac α-actin and its disease-associated mutants (p.A295S, p.R312H, p.E361G).
- To investigate the impact of these mutations on actin polymerization, calcium (Ca2+) sensitivity, and interactions with cardiac regulatory proteins.
Main Methods:
- Expression of recombinant wt and mutant cardiac α-actin using the baculovirus/Sf21 insect cell system.
- Biochemical assays including DNase I inhibition, electron microscopy, and TRITC-phalloidin staining to assess actin integrity and filament formation.
- Functional assays measuring Ca2+-sensitivity of myosin-S1 ATPase stimulation and pyrene-labeled tropomyosin movement.
Main Results:
- Actin variants maintained native structure and formed filaments with mutant-specific differences in length and straightness.
- HCM (p.A295S) and DCM (p.R312H, p.E361G) mutants exhibited altered Ca2+-sensitivity of myosin-S1 ATPase stimulation.
- Levosimendan corrected the reduced Ca2+-sensitivity in DCM mutants; cardiac myosin-binding protein-C affected Ca2+-sensitivity differently across mutants.
Conclusions:
- Cardiac actin mutations associated with HCM and DCM significantly alter actin filament properties and Ca2+-dependent contractility.
- The findings provide insights into the molecular basis of cardiomyopathies and highlight potential therapeutic targets, such as levosimendan for DCM.
Abstract:
Human wild type (wt) cardiac α-actin and its mutants p.A295S or p.R312H and p.E361G correlated with hypertrophic or dilated cardiomyopathy, respectively, were expressed by using the baculovirus/Sf21 insect cell system. The c-actin variants inhibited DNase I, indicating maintenance of their native state. Electron microscopy showed the formation of normal appearing actin filaments though they showed mutant specific differences in length and straightness correlating with their polymerization rates. TRITC-phalloidin staining showed that p.A295S and p.R312H exhibited reduced and the p.E361G mutant increased lengths of their formed filaments. Decoration of c-actins with cardiac tropomyosin (cTm) and troponin (cTn) conveyed Ca2+-sensitivity of the myosin-S1 ATPase stimulation, which was higher for the HCM p.A295S mutant and lower for the DCM p.R312H and p.E361G mutants than for wt c-actin. The lower Ca2+-sensitivity of myosin-S1 stimulation by both DCM actin mutants was corrected by the addition of levosimendan. Ca2+-dependency of the movement of pyrene-labeled cTm along polymerized c-actin variants decorated with cTn corresponded to the relations observed for the myosin-S1 ATPase stimulation though shifted to lower Ca2+-concentrations. The N-terminal C0C2 domain of cardiac myosin-binding protein-C increased the Ca2+-sensitivity of the pyrene-cTM movement of bovine, recombinant wt, p.A295S, and p.E361G c-actins, but not of the p.R312H mutant, suggesting decreased affinity to cTm.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Heart Failure II: Pathophysiology
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...

